Neovacs (LTS:0W8U) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0W8U Neovacs SA LTS:0W8U
4 GF Score
Price €16,000.00
View Full Analysis

What is Neovacs FFO per Share?

FFO per Share only applies to REITs.

LTS:0W8U
4GF Score
Neovacs SA LTS:0W8U
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neovacs Business Description

Address 3-5, Impasse Reille, Paris, FRA, 75014
Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.
4GF Score

Get the complete analysis for LTS:0W8U

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16,000.00
Price